Trial intelligence / Profile preview

Single shot vs continuous adductor canal block for TKA

NCT02730728Completed

Sponsor
University of Pennsylvania
Start
Nov 2015
Primary completion
Jun 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of ropivacaine in postoperative pain (3 arms), sponsored by University of Pennsylvania. Primary endpoint: Patients With Severe Pain at 48 Hours After Surgery. Started Nov 2015; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02730728.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02730728.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call